Nijmegen-based AI software company, Thirona has developed an AI algorithm to detect and quantify lung abnormalities related to cystic fibrosis (CF).
PRAGMA-AI aims to process faster and automated analysis of CT scans of patients with the condition, delivering an assessment in several seconds.
WHY IT MATTERS
CF is a rare genetic disorder with approximately 70,000 known cases worldwide,...
Dutch AI medical image analysis company, Thirona has obtained a license on a patent for the treatment of Cystic Fibrosis (CF).
The patent allows Thirona to develop an AI algorithm that will analyse CT scans to identify abnormalities in the lungs, ensuring that they are identified from an early age and that a personalised treatment plan can follow.
WHY IT MATTERS
Worldwide, there are approximately...
UK CONTACT TRACING APP SWITCH
In a major U-turn, the UK is switching from its existing centralised contact tracing app to the technology provided by Google and Apple.
At the Downing Street briefing, health secretary, Matt Hancock said the new app is months from being ready however said the government would not “put a date” on when the app will be launched.
In a joint statement from Baroness Dido...
Stockholm-based respiratory health startup NuvoAir is set to make its technology available in selected cystic fibrosis (CF) centres after entering a new partnership with Roche Italy.
This marks NuvoAir’s first CF deal with a pharma company.
WHY IT MATTERS
According to the UK-based Cystic Fibrosis Trust, the genetic condition is estimated to affect around 100,000 people globally. It causes a...
There’s been a lot of talk about sweat-centric technology, with hopeful researchers and digital health entrepreneurs citing the potential for wearables that measure the salty substance to offer up a bevy of biometric insights ranging from athletic performance to glucose monitoring. But the latest scientific undertaking suggests sweat-sensing wearables could go much further: diagnosing disease.
In...
The Inspiromatic inhaler.
Biopharmaceutical company Opko Health has acquired Israeli smart inhaler company Inspiro Medical for a sum in "the low eight figures", according to Opko's Director of Strategic Investment Les Funtleyder. The company will be using Inspiro's Inspiromatic technology to develop an app-connected inhaler that will be bundled with a forthcoming new drug for asthma, COPD, and...
Madison, Wisconsin-based Asthmapolis, which offers a FDA-cleared inhaler sensor and app for people with asthma, COPD, or cystic fibrosis, announced that it has raised $5 million in its first round of funding. The investment was led by The Social+Capital Partnership, a relatively new venture fund started by Chamath Palihapitiya, an early executive at Facebook who left to start the investment fund...
